A phase I hexaminolevulinate [hexyl aminolevulinate] (HAL) dose-finding study applying different formulations to the cervix in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Bladder cancer; Cervical intraepithelial neoplasia; Colorectal cancer
- Focus Adverse reactions
- Sponsors PhotoCure
- 15 Jan 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Aug 2007 New trial record.